Utilization of immunotherapy as a neoadjuvant treatment in liver transplant recipients with hepatobiliary carcinoma

BackgroundHepatobiliary carcinoma (HBC) ranks as the sixth most prevalent cancer worldwide. Orthotopic liver transplantation (OLT) has emerged as a highly effective treatment option for early-stage HBC. Immunotherapies as neoadjuvant options are now being actively investigated in the transplant onco...

Descrición completa

Detalles Bibliográficos

Principais autores:	Maen Abdelrahim, Abdullah Esmail, Ashton A. Connor, Sudha Kodali, Ashish Saharia, David W. Victor, Caroline J. Simon, Yee Lee Cheah, Sunyoung S. Lee, Milind Javle, Ahmed O. Kaseb, Rafik Mark Ghobrial
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2026-07-01
Series:	Frontiers in Oncology
Assuntos:	cholangiocarcinoma hepatobiliary carcinoma hepatocellular carcinoma immunotherapy liver transplant Milan criteria
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1866870/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!